Commission Regulation (EU) 2022/711 of 6 May 2022 refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children’s development and health (Text with EEA relevance)

• CELEX: Regulation (EU) 2022/711
• Articles: 3

Article 1

The health claims listed in the Annex to this Regulation shall not be included in the Union list of permitted claims as provided for in Article 13(3) of Regulation (EC) No 1924/2006.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX Rejected health claims

ANNEX

Rejected health claims

Application – Relevant provisions of Regulation (EC) No 1924/2006

Nutrient, substance, food or food category

Claim

EFSA opinion reference

Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data

GlycoLite TM – A proprietary standardised aqueous extract from white kidney bean ( Phaseolus vulgaris L.)

GlycoLite™ helps to reduce body weight

Q-2018-00611

Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data

Lozenges with two Lactobacillus reuteri strains:

Lactobacillus reuteri DSM 17938 and Lactobacillus reuteri ATCC PTA 5289, approximately equal amount of each strain (total minimum amount of 1 × 10 8 CFU/lozenge of each bacterial strain)

Lozenges containing Lactobacillus reuteri DSM 17938 and Lactobacillus reuteri ATCC PTA 5289 support normal gum function

Q-2019-00383